These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5783221)

  • 21. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
    Ivanova ES
    Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ethionamide and cycloserine in the treatment of middle-aged and aged patients with pulmonary tuberculosis].
    Vasil'eva IR; Zhmudskaia EV; Trifonova VK; Chesmochakova IV
    Probl Tuberk; 1970; 48(9):21-4. PubMed ID: 5518269
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 24. [Psychiatric and neurological symptoms caused by cycloserine poisoning].
    Nakamura K
    Seishin Shinkeigaku Zasshi; 1968 Jun; 70(6):503-21. PubMed ID: 5749977
    [No Abstract]   [Full Text] [Related]  

  • 25. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M; Szymański A; Chetkowski A; Tarocińska B
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract]   [Full Text] [Related]  

  • 28. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 29. Side effects of cycloserine.
    Helmy B
    Scand J Respir Dis Suppl; 1970; 71():220-5. PubMed ID: 5271989
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerance to ethionamid and PAS in original treatment of tuberculous patients.
    Verbist L; Prignot J; Cosemans J; Gyselen A
    Scand J Respir Dis; 1966; 47(4):225-35. PubMed ID: 5182290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the electroencephalogram and neuro-psychic disorders in patients with pulmonary tuberculosis during treatment with cycloserine].
    Chelnokova NV
    Antibiotiki; 1968 Oct; 13(10):918-25. PubMed ID: 5707364
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of combined use of cycloserine in pulmonary tuberculosis.
    Tello F
    Scand J Respir Dis Suppl; 1970; 71():162-7. PubMed ID: 5271979
    [No Abstract]   [Full Text] [Related]  

  • 35. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.
    Bucco T; Meligrana G; De Luca V
    Scand J Respir Dis Suppl; 1970; 71():259-65. PubMed ID: 5271998
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of ethionamide in the clincal treatment of pulmonary tuberculosis].
    Mamolat AS; Bialik IB
    Vrach Delo; 1965 Jun; 6():35-9. PubMed ID: 5856046
    [No Abstract]   [Full Text] [Related]  

  • 38. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 39. [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine].
    Schumann C
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):295-302. PubMed ID: 5756628
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M
    Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.